Palboxen (palbociclib)

Palboxen 125mg Capsules contain Palbociclib, a targeted cancer medicine that belongs to the cyclin-dependent kinase (CDK) 4/6 inhibitor class. It works by blocking proteins involved in cancer cell growth and division.

Key Information

• Active Ingredient: Palbociclib
• Strength: 125mg per capsule
• Quantity: 21 capsules per pack
• Manufacturer: Everest Pharmaceuticals Ltd.
• Uses: Used with hormonal therapy for certain hormone receptor-positive (HR+) and HER2-negative advanced or metastatic breast cancers.
• Administration: Usually taken once daily for 21 consecutive days, followed by a 7-day break, as directed by a healthcare professional.
• Common Side Effects: Fatigue, nausea, diarrhea, mouth sores, hair loss and increased risk of infection may occur.
• Important: Regular blood tests may be required to monitor blood cell counts and liver function during treatment.

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare professional before starting or changing any medication.